/
MET
$85.88-$0.07 (-0.08%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$55.3B
643M shares
52-week range
$67.33 – $89.62
83% from low
Sector
LIFE INSURANCE
Exchange
NYSE
CS
Borrow rate
0.30%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$26.03
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.94B | $69.62B | $67.89B | $63.37B | $67.97B | $67.71B | $69.94B | $77.08B |
| Cost of revenue | $52.04B | $53.43B | $52.42B | $46.53B | $49.03B | $50.42B | $50.94B | $49.06B |
| Gross profit | $15.90B | $16.19B | $15.47B | $16.84B | $18.94B | $17.29B | $19.00B | $28.02B |
| Gross margin | 23.4% | 23.3% | 22.8% | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $6.31B | $6.79B | $6.93B | $8.52B | $6.36B | $2.16B | $5.62B | $4.66B |
| EBITDA | $8.06B | $8.38B | $8.46B | $10.13B | $7.97B | $3.92B | $7.37B | $6.47B |
| Net income | $5.12B | $5.90B | $5.41B | $6.86B | $5.28B | $1.58B | $4.43B | $3.38B |
| Net margin | 7.5% | 8.5% | 8.0% | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (diluted) | 4.91 | 6.06 | 5.68 | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $80.6B | $9.93 | $9.65–$10.49 | 11 |
| 2027 | $84.1B | $10.99 | $10.71–$11.50 | 11 |
| 2028 | $87.9B | $12.25 | $10.29–$13.27 | 6 |
| 2029 | $92.9B | $13.50 | $13.08–$13.83 | 4 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$199.09
Price
$85.88
Implied upside
+132%
Peer comparison
MetLife, Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
www.metlife.com- Employees
- 46,000
- IPO / List date
- Apr 5, 2000
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds MET.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 626,530 | $44.3M |
| Renaissance Technologiesas of 2026-03-31 | 14,700 | $1.0M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.67% ($2.29/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-12 | $0.5925 | 2026-06-09 |
| 2026-02-03 | $0.5675 | 2026-03-10 |
| 2025-11-04 | $0.5675 | 2025-12-09 |
| 2025-08-05 | $0.5675 | 2025-09-09 |
| 2025-05-06 | $0.5675 | 2025-06-10 |
| 2025-02-04 | $0.5450 | 2025-03-11 |
| 2024-11-05 | $0.5450 | 2024-12-16 |
| 2024-08-06 | $0.5450 | 2024-09-10 |
| 2024-05-06 | $0.5450 | 2024-06-11 |
| 2024-02-05 | $0.5200 | 2024-03-14 |
Recent trades on TradeandTell
No one on the platform has traded MET yet.
